GSK N 218 "VOIN", Orenburg Oblast

Economic indicators

Net profit (RAS) of GSK N 218 VOIN made up 0 RUB over 2022 compared to 4.00 thousand RUB over 2021, the company informed.

Revenue remained in the accounting period at the same level and made up 254.00 thousand RUB compared to 254.00 thousand RUB 254.00 thousand RUB; sales profit went up 2.00 times to 8.00 thousand RUB from 4.00 thousand RUB.

Revenue remained in the accounting period at the same level and made up 254.00 thousand RUB compared to 254.00 thousand RUB 254.00 thousand RUB; cost of goods sold decreased ? times to 0.00 thousand RUB from 254.00 thousand RUB.

Net profit (RAS) of GSK N 218 VOIN made up 0 RUB over 2020 compared to 30.00 thousand RUB over 2019, the company informed.

Revenue decreased in the accounting period by 38.80% to 254.00 thousand RUB from 415.00 thousand RUB in 2019; cost of goods sold decreased by 34.03% to 254.00 thousand RUB from 385.00 thousand RUB; sales profit made up 0 RUB compared to 30.00 thousand RUB.

Net profit (RAS) of GSK N 218 VOIN dropped in 2019 by 14.29% to 30.00 thousand RUB from 35.00 thousand RUB over the same period in 2018, the company informed.

Revenue remained in the accounting period at the same level and made up 415.00 thousand RUB compared to 415.00 thousand RUB 415.00 thousand RUB; cost of goods sold grew by 1.32% to 385.00 thousand RUB from 380.00 thousand RUB; sales profit fell by 14.29% to 30.00 thousand RUB from 35.00 thousand RUB.

Net profit (RAS) of GSK N 218 VOIN dropped in 2018 by 8.00% to 23.00 thousand RUB from 25.00 thousand RUB over the same period in 2017, the company informed.

Revenue remained in the accounting period at the same level and made up 415.00 thousand RUB compared to 414.00 thousand RUB 414.00 thousand RUB; cost of goods sold decreased by 2.31% to 380.00 thousand RUB from 389.00 thousand RUB; sales profit went up by 40.00% to 35.00 thousand RUB from 25.00 thousand RUB.

Net profit (RAS) of GSK N 218 VOIN dropped in 2017 by 3.85% to 25.00 thousand RUB from 26.00 thousand RUB over the same period in 2016, the company informed.

Revenue increased in the accounting period by 0.98% to 414.00 thousand RUB from 410.00 thousand RUB over 2016; cost of goods sold grew by 1.30% to 389.00 thousand RUB from 384.00 thousand RUB; sales profit fell by 3.85% to 25.00 thousand RUB from 26.00 thousand RUB.

Net profit (RAS) of GSK N 218 VOIN grew over 2016 by 17.86% to 33.00 thousand RUB from 28.00 thousand RUB over 2015, the company informed.

Revenue remained in the accounting period at the same level and made up 348.00 thousand RUB compared to 348.00 thousand RUB 348.00 thousand RUB; cost of goods sold remained at the same level amounting to 315.00 thousand RUB compared to 315.00 thousand RUB; sales profit matched the previous year’s result amounting to 33.00 thousand RUB.

Net profit (RAS) of GSK 218 Voin grew over 2014 1.94 times to 163.00 thousand RUB from 84.00 thousand RUB over 2013, the company informed.

Revenue increased in the accounting period 2.00 times to 168.00 thousand RUB from 84.00 thousand RUB over 2013; sales profit went up 2.00 times to 168.00 thousand RUB from 84.00 thousand RUB.

Companies in the region

• STROYPROEKT
• BRIZ
• NZSH
• OMEGA-SERVIS
• EKSPEDITSIYA - SAMARA